Related references
Note: Only part of the references are listed.Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines
Salah Ghabri et al.
PHARMACOECONOMICS (2018)
Smoking Cessation: A Comparison of Two Model Structures
Becky Pennington et al.
PHARMACOECONOMICS (2018)
How Qualitative Methods Can be Used to Inform Model Development
Samantha Husbands et al.
PHARMACOECONOMICS (2017)
A systematic literature review of the key challenges for developing the structure of public health economic models
Hazel Squires et al.
INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2016)
Structural Uncertainty of Markov Models for Advanced Breast Cancer: A Simulation Study of Lapatinib
Quang A. Le
MEDICAL DECISION MAKING (2016)
Relationship between frailty, physical performance and quality of life among nursing home residents: the SENIOR cohort
F. Buckinx et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
James F. O'Mahony et al.
PHARMACOECONOMICS (2015)
Exploring Structural Uncertainty in Model-Based Economic Evaluations
Hossein Haji Ali Afzali et al.
PHARMACOECONOMICS (2015)
Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
L Andronis et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance
Gerardus W. J. Frederix et al.
PHARMACOECONOMICS (2014)
Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models
Paul Tappenden et al.
PHARMACOECONOMICS (2014)
When Is a Model Good Enough? Deriving the Expected Value of Model Improvement via Specifying Internal Model Discrepancies
Mark Strong et al.
SIAM-ASA JOURNAL ON UNCERTAINTY QUANTIFICATION (2014)
Estimating Health State Utility Values for Joint Health Conditions: A Conceptual Review and Critique of the Current Evidence
Roberta Ara et al.
MEDICAL DECISION MAKING (2013)
Assessing Personalized Medicines in Australia: A National Framework for Reviewing Codependent Technologies
Tracy Merlin et al.
MEDICAL DECISION MAKING (2013)
Model Performance Evaluation (Validation and Calibration) in Model-based Studies of Therapeutic Interventions for Cardiovascular Diseases A Review and Suggested Reporting Framework
Hossein Haji Ali Afzali et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
K. Claxton et al.
HEALTH TECHNOLOGY ASSESSMENT (2012)
Regression Estimators for Generic Health-Related Quality of Life and Quality-Adjusted Life Years
Anirban Basu et al.
MEDICAL DECISION MAKING (2012)
Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
J. Jaime Caro et al.
MEDICAL DECISION MAKING (2012)
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
Mark Roberts et al.
MEDICAL DECISION MAKING (2012)
A Critical Review of Model-Based Economic Studies of Depression Modelling Techniques, Model Structure and Data Sources
Hossein Haji Ali Afzali et al.
PHARMACOECONOMICS (2012)
Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies
Roberta Ara et al.
VALUE IN HEALTH (2012)
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
Andrew H. Briggs et al.
VALUE IN HEALTH (2012)
A proposed model for economic evaluations of major depressive disorder
Hossein Haji Ali Afzali et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2012)
Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models: A Practical Guide
Joke Bilcke et al.
MEDICAL DECISION MAKING (2011)
A Framework for Addressing Structural Uncertainty in Decision Models
Christopher H. Jackson et al.
MEDICAL DECISION MAKING (2011)
Cautions Regarding the Fitting and Interpretation of Survival Curves Examples from NICE Single Technology Appraisals of Drugs for Cancer
Martin Connock et al.
PHARMACOECONOMICS (2011)
Model Averaging in the Presence of Structural Uncertainty about Treatment Effects: Influence on Treatment Decision and Expected Value of Information
Malcolm J. Price et al.
VALUE IN HEALTH (2011)
Eliciting Distributions to Populate Decision Analytic Models
Laura Bojke et al.
VALUE IN HEALTH (2010)
Populating an Economic Model with Health State Utility Values: Moving toward Better Practice
Roberta Ara et al.
VALUE IN HEALTH (2010)
Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods
Laura Bojke et al.
VALUE IN HEALTH (2009)
A taxonomy of model structures for economic evaluation of health technologies
Alan Brennan et al.
HEALTH ECONOMICS (2006)
Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs
M. Brisson et al.
MEDICAL DECISION MAKING (2006)
Cost-effectiveness as an outcome in randomized clinical trials
Mark A. Hlatky et al.
CLINICAL TRIALS (2006)
A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions
PW Sullivan et al.
CNS DRUGS (2004)
Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR task force on good research practices-modeling studies
MC Weinstein et al.
VALUE IN HEALTH (2003)
Share Paper
